Vanda Pharmaceuticals
VNDA
#8452
Rank
$0.30 B
Marketcap
$4.99
Share price
-0.80%
Change (1 day)
1.63%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $0.19 Billion USD

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are $0.19 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.16 B37.48%
2024-12-31$0.11 B13.65%
2023-12-31$0.10 B-3.29%
2022-12-31$0.10 B20.46%
2021-12-31$88.86 M10.82%
2020-12-31$80.19 M10.15%
2019-12-31$72.8 M28.38%
2018-12-31$56.7 M-23.41%
2017-12-31$74.03 M-6.33%
2016-12-31$79.04 M-1.22%
2015-12-31$80.02 M635.03%
2014-12-31$10.88 M-89.03%
2013-12-31$99.22 M-20.96%
2012-12-31$0.12 B-15.82%
2011-12-31$0.14 B-14.95%
2010-12-31$0.17 B-13.48%
2009-12-31$0.20 B5078.98%
2008-12-31$3.91 M-70.2%
2007-12-31$13.13 M38.18%
2006-12-31$9.5 M86.78%
2005-12-31$5.08 M181.31%
2004-12-31$1.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$116.09 B 60,274.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$80.08 B 41,550.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$115.63 B 60,040.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$108.40 B 56,277.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$87.81 B 45,571.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$65.31 B 33,868.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
$0.26 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA